Touchlight and Odimma Therapeutics Announce Clinical Materia

Touchlight and Odimma have entered into an agreement to develop and supply clinical material for Odimma's neoantigen program Touchlight, a biotechnology company pioneering enzymatic DNA production

Related Keywords

France , London , City Of , United Kingdom , French , Robin Bodicoat , Pascale Balducchi , Kostenloser Wertpapierhandel , Jean Marc Limacher , Jessica Matta , Agnes Stephens , Twitter , Odimma Therapeutics , Marc Limacher , Jonjo Cordey , Touchlight , Uzodimma , Herapeutics , Nnounce , Linical , Material , Supply , Agreement , Evelop , Personalised , Dancer , Therapy , Utilising , Oggybone ,